Irritable bowel syndrome. Irritable bowel syndrome,Irritable bowel syndrome with diarrhoea, Irritable bowel syndrome without diarrhoea
Conditions
Interventions
Intervention 1: intervention group: in people with inclusion criteria to be given 250 mg oral Teucrium polium capsule , 4 times daily , for one month. Intervention 2: control group: in people with inc
Treatment - Drugs
intervention group: in people with inclusion criteria to be given 250 mg oral Teucrium polium capsule , 4 times daily , for one month.
control group: in people with inclusion criteria to be given oral placebo capsule (contain 250 mg of Starch powder) 4 times daily for one month.
Sponsors
Roghayeh Mahdi
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 18 - 65 years old; receiving written informed consent from patients; having IBS. Exclusion criteria: individuals will not to continue the study; any chronic diseases (cardiac disease, prostate hyperplasia, kidney failure, liver disease, glaucoma); having allergy to herbal products (specially including Teucrium polium); any use of herbal medications in last 3 months; pregnancy.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total IBS symptom Score. Timepoint: before intervention, one month after intervention. Method of measurement: questionnaire.;Abdominal pain severity. Timepoint: before intervention, one month after intervention. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Spasm. Timepoint: before intervention, one month after intervention. Method of measurement: questionnaire.;Bloating. Timepoint: before intervention, one month after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRamin Abrishami
Islamic Azad University of Pharmaceutical Sciences
Outcome results
None listed